BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| dietary fiber - Eubacterium limosum |
👶
<i>Bacteroides thetaiotaomicron</i> Starch Utilization Promotes Quercetin Degradation and Butyrate Production by <i>Eubacterium ramulus</i>. Frontiers in microbiology (Front Microbiol ) Vol: 10 Issue Pages: 1145 Pub: 2019 Epub: 2019 May 29 Authors Rodriguez-Castaño GP , Dorris MR , Liu X , Bolling BW , Acosta-Gonzalez A , Rey FE , Html Article Publication |
| dietary fiber - Eubacterium limosum |
👶
Kale improves bowel movements in constipated women and affects some intestinal microbes and metabolites: a pilot study. Frontiers in nutrition (Front Nutr ) Vol: 10 Issue Pages: 1247683 Pub: 2023 Epub: 2023 Nov 29 Authors Nishimoto Y , Salim F , Yamauchi Y , Mori Y , Murakami S , Suzuki A , Fukuda S , Yamada T , Html Article Publication |
| dietary fiber - Eubacterium limosum |
👶
The role of short-chain fatty acids in microbiota-gut-brain communication. Nature reviews. Gastroenterology & hepatology (Nat Rev Gastroenterol Hepatol ) Vol: 16 Issue 8 Pages: 461-478 Pub: 2019 Aug Epub: Authors Dalile B , Van Oudenhove L , Vervliet B , Verbeke K , Publication Publication |
| dietary fiber - Eubacterium limosum |
👶
Concentrated Raw Fibers Enhance the Fiber-Degrading Capacity of a Synthetic Human Gut Microbiome. International journal of molecular sciences (Int J Mol Sci ) Vol: 22 Issue 13 Pages: Pub: 2021 Jun 25 Epub: 2021 Jun 25 Authors Steimle A , Neumann M , Grant ET , Turner JD , Desai MS , Publication |
| dietary fiber - Eubacterium limosum |
📓
Positive Synergistic Effects of Quercetin and Rice Bran on Human Gut Microbiota Reduces Enterobacteriaceae Family Abundance and Elevates Propionate in a Bioreactor Model. Frontiers in microbiology (Front Microbiol ) Vol: 12 Issue Pages: 751225 Pub: 2021 Epub: 2021 Sep 30 Authors Ghimire S , Wongkuna S , Sankaranarayanan R , Ryan EP , Bhat GJ , Scaria J , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
